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Background: Minor saponins or human intestinal bacterial metabolites, such as ginsenosides Rg3, F2,
Rh2, and compound K, are more pharmacologically active than major saponins, such as ginsenosides Rb1,
Rb2, and Rc. In this work, enzymatic hydrolysis of ginsenoside Rb1 was studied using enzyme prepa-
rations from cultured mycelia of mushrooms.
Methods: Mycelia of Armillaria mellea, Ganoderma lucidum, Phellinus linteus, Elfvingia applanata, and
Pleurotus ostreatus were cultivated in liquid media at 25C for 2 wk. Enzyme preparations from cultured
mycelia of ﬁve mushrooms were obtained by mycelia separation from cultured broth, enzyme extraction,
ammonium sulfate (30e80%) precipitation, dialysis, and freeze drying, respectively. The enzyme prep-
arations were used for enzymatic hydrolysis of ginsenoside Rb1.
Results: Among the mushrooms used in this study, the enzyme preparation from cultured mycelia of
A. mellea (AMMEP) was found to convert ginsenoside Rb1 into compound K with a high yield, while
those from G. lucidum, P. linteus, E. applanata, and P. ostreatus produced remarkable amounts of ginse-
noside Rd from ginsenoside Rb1. The enzymatic hydrolysis pathway of ginsenoside Rb1 by AMMEP was
Rb1 / Rd / F2 / compound K. The optimum reaction conditions for compound K formation from
ginsenoside Rb1 were as follows: reaction time 72e96 h, pH 4.0e4.5, and temperature 45e55C.
Conclusion: AMMEP can be used to produce the human intestinal bacterial metabolite, compound K,
from ginsenoside Rb1 with a high yield and without food safety issues.
Copyright 2015, The Korean Society of Ginseng, Published by Elsevier. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The root of Panax ginsengMeyer (Araliaceae) has been used as a
folk medicine to cure diseases andmaintain health for thousands of
years in Asian countries such as Korea, China, and Japan. Ginseng
saponins, i.e., ginsenosides, have come to be regarded as the major
active components responsible for the pharmacological effects of
ginseng. So far, > 150 ginsenoside derivatives have been identiﬁed
from roots, leaves, fruits, ﬂower buds, processed P. ginseng prod-
ucts, and other Panax spp [1]. Pharmacological effects of ginseno-
sides frequently depend on the type or site of the attached sugare and Technology, Chonbuk Natio
n Research Institute, Daejeon 305
orean Society of Ginseng, Publishemoieties in dammarane- or oleanane-type aglycones. The major
saponins in the root of P. ginseng are ginsenosides Rb1, Rb2, Rc, Rd,
Re, and Rg1, which constitute > 80e90% of total ginsenosides [2].
However, these naturally occurring major ginsenosides are
poorly absorbed by the human intestinal tract because of their large
molecular size, low solubility, and poor permeability across the cell
membrane [3,4]. By contrast,many studies have indicated thatmajor
saponins, such as ginsenosides Rb1, Rb2, and Rc, are deglycosylated
by intestinal bacteria or digestive enzymes after oral intake, and are
converted tominor ginsenosides such as ginsenosidesMc1,Mc, CeO,
CeY, Rg3, F2, and compoundK [5,6]. Especially, compoundK is one ofnal University, Iksan 570-752, Korea.
-805, Korea.
d by Elsevier. This is an open access article under the CC BY-NC-ND license (http://
J Ginseng Res 2016;40:105e112106the human intestinal bacterial metabolites of protopanaxadiol-type
saponins, such as ginsenosides Rb1, Rb2, Rc, and Rd.
Interestingly, compound K does not exist in natural ginseng. It
has various pharmacological activities such as antigenotoxic ac-
tivity [7], antiallergic effect [8], and prevention of tumor invasion
and metastasis [9], as well as hepatoprotective [10] and anti-
inﬂammatory activities [11]. Various methods, such as mild acid
hydrolysis [12], alkaline cleavage [13], and microbial and enzymatic
degradation [14], have previously been reported for producing
minor ginsenosides Rg3, F2, Rh2, and compound K from major
ginsenosides. Microbial or enzymatic hydrolysis methods are
considered more favorable than conventional chemical methods
due to their performance under milder reaction conditions,
simplicity of reaction steps, and high regio- and diaster-
eoselectivities [15]. However, in previous studies, some attempts to
produce minor ginsenosides using microbial and enzymatic
methods were limited by low yields, complexity of enzyme isola-
tion, or food safety problems.
Another approach to enhance the contents of minor ginse-
nosides in white ginseng, red ginseng extract, or processed
ginseng products is to use mushroom mycelial fermentation.
Recently, some studies reported that fermentation of ginseng
extracts or ginseng extraction residue with commercial edible
mushrooms such as Ganoderma lucidum, Phellinus linteus, Lenti-
nus edodes, Grifolia frondosa, Hericium erinaceum, and Codyceps
spp. could enhance the concentration of minor ginsenosides in
the products. However, these studies reported that the major
transformation product from major ginsenosides Rb1, Rb2, and
Rc, when ginseng extracts or ginseng extraction residues were
fermented with these mushrooms, was ginsenoside Rd rather
than minor ginsenosides such as ginsenoside Rg3, F2, Rh2, or
compound K [16e18].
In a preliminary experiment, we screened a variety of edible
and/or medicinal mushrooms for activities in the production of
minor ginsenosides and intestinal bacterial metabolites from
ginsenoside Rb1, one of the protopanaxadiol-type saponins. From
the results, the intestinal bacterial metabolite compound K was
found to be produced with a high yield from ginsenoside Rb1 by
enzyme preparation from the cultured mycelia of Armillaria mel-
lea (AMMEP), whereas enzyme preparation from the cultured
mycelia of G. lucidum, P. linteus, Elfvingia applanata, and Pleurotus
ostreatus produced remarkable amounts of ginsenoside Rd from
ginsenoside Rb1. A. mellea, known as honey mushroom, is
commonly used in folk medicine as a health-promoting food in
various forms and for dietary supplementation [19,20]. In tradi-
tional Chinese medicine, A. mellea is used for treating a variety of
complaints including palsy, headache, hypertension, insomnia,
vertigo, and neurasthenia. It also exerts neuroprotective effects
[19,21]. Therefore, this paper describes the enzymatic formation
of the human intestinal microbial metabolite compound K from
ginsenoside Rb1 by AMMEP.
2. Materials and methods
2.1. Materials
Ginsenoside Rb1 was isolated from fresh P. ginseng roots ac-
cording to the usual procedure [22]. The isolated compound was
identiﬁed by comparing its spectral data and retention time from
HPLC with those of an authentic sample. Authentic standards and
standard mixtures of ginsenosides Rb1, Rb2, Rc, Rd, Rg3 (S), F2, Rh2
(S), and compound K were kindly donated by the Korea Ginseng
Corporation Research Institute, Daejeon, Korea. The concentration
of each ginsenoside in the standard mixture was 1,000 ppm
(1.0 mg/mL). Silica gel F254 TLC plate and silica gel 60 (0.040e0.063 mm) for column chromatography were purchased from
Merck Co. (Darmstadt, Germany). The compounds p-nitrophenol
(PNP), PNP-a-D-glucopyranoside, PNP-b-D-glucopyranoside, PNP-
a-D-galactopyranoside, PNP-b-D-galactopyranoside, PNP-a-L-ara-
binofuranoside, PNP-a-L-arabinopyranoside, and PNP-b-D-xylo-
pyranoside were purchased from Sigma-Aldrich Co. (St. Louis, MO,
USA). Other reagents used were of analytical grade and were pro-
cured from commercial sources.
2.2. TLC analysis
TLC was performed on silica gel 60 F254 plate with CHCl3e
CH3OHeH2O (65:35:10, v/v/v, lower phase) as the developing sol-
vent. The spots on the TLC were detected by spraying 10% (w/v)
H2SO4 in ethanol and heating at 120C for 10 min.
2.3. HPLC and LC/MS analysis
HPLC analysis was performed using an HPLC system (Waters,
Millford, MA, USA) equipped with a 600E system controller, a 717
plus autosampler, and a 486UVdetectorwith a YMC-Pack Pro C18 RS
column (250 mm  4.6 mm, 5 mm ID; YMC Co., Ltd, Shimogyo-ku,
Kyoto, Japan). The mobile phase consisted of water (A) and aceto-
nitrile (B) at ratios of (A:B) 70:30 (0e5 min), 70:30 (5e15 min),
43:57 (15e25min), 30:70 (25e30min), and 70:30 (30e40min) at a
ﬂow rate of 0.8 mL/min. Detection absorbance was 203 nm. LC/MS
analysis was performed with a Waters ACQUITY UPLC system
composed of a binary solvent manager and a photodiode array de-
tector at 203 nm. Chromatographic separationwas accomplished on
an ACQUITY BEH C18 column (100 mm  2.1 mm, 1.7 mm; Waters).
The column temperature was 40C. The binary gradient elution
system consisted of 0.01% formic acid inwater (A) and 0.01% formic
acid in acetonitrile (B). Separationwas achieved using the following
gradient program: 0e1 min (15% B), 1e15 min (30% B), 15e20 min
(38% B), 20e24min (43% B), 27e31min (55% B), 31e35min (70% B),
35e38 min (90% B), and 38e43.0 min (15% B). The ﬂow rate was set
at 0.6 mL/min. MS analysis was performed on a Waters Xevo
quadruple-time-of-ﬂight MS equipped with an electrospray ioni-
zation source under negative ion mode. The conditions for MS
analysis were as follows: drying gas N2 ﬂow rate of 12 L/min, cone
gas temperature of 350C, and nebulizer pressure of 50 psi. The
capillary voltage was set to 4.0 kV.
2.4. Preparation of crude enzymes from cultured mycelia of
mushrooms
Strains of A. mellea, G. lucidum, P. linteus, E. applanata, and
P. ostreatus were purchased from Korean Agricultural Culture
Collection, Suwon, Korea, and preincubated on a potato dextrose
agar (DB Difco, NJ, USA) for 6 d at 25C. All nutrient media were
sterilized at 121C for 30 min. The strains were inoculated with
germinated-malt media (11 Brixo) sacchariﬁed at 65C with four-
fold tap water for 8 h, and then cultured for 2 wk at 25C. The scale-
up production of mushroom mycelia was performed in a 4 L
Erlenmeyer ﬂask containing 1 L of germinated-malt media for 3 wk
at 25e26C with gentle shaking (120 rpm). The culture broth was
centrifuged (9,000g, 20 min) to separate the mycelia from the
broth. Themycelia mass was washedwith distilled water to remove
residual broth, and then lyophilized. Each lyophilized mycelium
(100 g) was mixed with 500 mL of 0.1M sodium phosphate buffer
(pH 6.0) with gentle stirring for 12 h at 4C and then homogenized
with an Omni mixer homogenizer (Omni International, NW Ken-
nesaw, GA, USA) for 1 min at 4C. The slurry was squeezed through
a cheese cloth and the ﬁltrate was centrifuged at 9000g for 20 min
at 4C. Solid ammonium sulfate was added to the supernatant
Fig. 1. TLC analysis of hydrolysis of ginsenoside Rb1 by enzyme preparations from
cultured mycelia of mushrooms. The reaction mixture (2.0 mL) containing 2.0 mg of
ginsenoside Rb1 in 0.2 mL of methanol and each enzyme preparation containing 1.1 U
b-glucosidase activity in 1.8 mL of 0.1M sodium acetate buffer (pH 4.8) was incubated
for 96 h at 37C. The reaction mixture was extracted twice with 2.0 mL of n-butanol
saturated with water. The n-butanol fraction was concentrated to dryness in vacuo, and
the residue was dissolved in 1.0 mL of methanol. TLC of the methanol extract was
performed on a silica gel 60 F254 plate with CHCl3eCH3OHeH2O (65:35:10, lower
phase). The spots on the TLC were detected by spraying 10% H2SO4 in ethanol and
heating at 120C for 10 min. AM, Armillaria mellea; EA, Elfvingia applanata; GL,
Ganoderma lucidum; PL, Phellinus linteus; PO, Pleurotus ostreatus.
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centrifugation at 9,000g for 20 min at 4C, the precipitate was
dissolved in 10mM sodium acetate buffer (pH 6.0). After overnight
dialysis, the solution was centrifuged at 9,000g for 20 min at 4C,
and the supernatant was lyophilized.
2.5. Enzyme assay and enzyme characterization
Activity of b-glucosidase was assayed using PNP-b-D-glucopyr-
anoside as a substrate. A reaction mixture (1.0 mL) containing
0.1 mL of PNP-b-D-glucopyranoside (10mM), 0.1 mL of enzyme
solution containing 0.02 mg of enzyme preparation, and 0.8 mL of
0.1M sodium acetate buffer (pH 4.8) was incubated for 30 min at
37C. The reactionwas terminated by adding 1.0 mL of 0.1MNa2CO3
solution. The released PNP was measured immediately using a UVe
visible spectrophotometer (UV-1601; Shimadzu, Tokyo, Japan) at
400 nm. The amount of PNP released was quantiﬁed using the
concentration plot of the PNP standard. One unit of b-glucosidase
activity was expressed as the amount of enzyme required to release
1 mmole of PNP per min under the assay conditions.
The effect of pH on the hydrolyzing activity of PNP-b-D-gluco-
pyranoside was assayed at 37C in the following buffer solutions
(each at 0.1M): glycineeHCl (pH 3.0), sodium acetate (pH 4.0e5.5),
sodium phosphate (pH 6.0e7.0), Tris-HCl (pH 8.0e9.0), and
glycineeNaOH (pH 10.0). The pH stability of the enzyme was
examined by measuring residual activity after incubating it in each
buffer for 4 h at 37C. The results were expressed as a percentage of
the activity obtained at the optimum pH. The effect of temperature
on the hydrolyzing activity of PNP-b-D-glucopyranoside was
assayed by incubating the enzyme for 4 h at various temperatures
ranging from 25C to 70C at pH 4.8. The temperature stability of
the enzyme was determined by measuring the residual activity
after preincubating the enzyme in 0.1M acetate buffer (pH 4.8) for
4 h at different temperatures (20e70C). Immediately after cooling
the test samples in an ice bath, the residual activity was determined
using PNP-b-D-glucopyranoside as a substrate. The results were
expressed as a percentage of the activity obtained at an optimum
temperature. The following substrates were also tested with the
same assay method used for PNP-b-D-glucopyranoside: PNP-a-D-
glucopyranoside, PNP-a-D-galactopyranoside, PNP-b-D-gal-
actopyranoside, PNP-a-L-arabinofuranoside, PNP-a-L-arabinopyr-
anoside, and PNP-b-D-xylopyranoside.
2.6. Enzymatic hydrolysis of ginsenoside Rb1
To investigate the hydrolysis pattern of ginsenoside Rb1 by
enzyme preparations from the cultured mushroom mycelia, the
reaction mixture (2.0 mL) containing 2.0 mg of ginsenoside Rb1 in
0.2 mL of methanol and each enzyme preparation containing 1.1 U
of b-glucosidase activity in 1.8 mL of 0.1M sodium acetate buffer
(pH 4.8) were incubated for 96 h at 37C. The reaction mixture was
extracted twice with 2.0 mL of n-butanol saturated with water. The
n-butanol fraction was concentrated to dryness in vacuo, and the
residuewas dissolved in 1.0mL of methanol. To investigate the time
course of ginsenoside Rb1 hydrolysis by AMMEP, a 20 mL reaction
mixture containing 20 mg of ginsenoside Rb1 in 2.0 mL methanol,
30 mg of AMMEP containing 11 U of b-glucosidase, and 0.1M so-
dium acetate buffer (pH 4.8) was incubated for 96 h at 37C with
gentle shaking. The reaction mixture (2 mL) was withdrawn at
regular intervals, and extracted twice with 2.0 mL of n-butanol
saturated with water. The n-butanol fraction was concentrated to
dryness in vacuo. The residue was dissolved in 1.0 mL of methanol,
and subjected to TLC, HPLC, and LC/MS analyses.
For enzyme characterization of the ginsenoside Rb1 hydrolysis,
the reaction mixture (2.0 mL) containing 2.0 mg of ginsenoside Rb1in 0.2 mL methanol, AMMEP containing 1.1 U of b-glucosidase, and
1.8 mL of 0.1M acetate buffer (pH 4.8) was incubated at 37C with
gentle shaking. After 24 h of incubation, each reaction mixture was
extracted twice with 2.0 mL of n-butanol saturated with water. The
n-butanol fraction was concentrated to dryness in vacuo, and the
residuewas dissolved in 1.0 mL of methanol. The effect of pH on the
hydrolyzing activity of ginsenoside Rb1 was examined using gin-
senoside Rb1 as a substrate at 37C in the following buffer solutions
(each at 0.1M): glycineeHCl (pH 3.0), sodium acetate (pH 4.0e5.5),
sodium phosphate (pH 6.0e7.0), Tris-HCl (pH 8.0), and glycinee
NaOH (pH 9.0e10.0). The effect of temperature on the hydrolyzing
activities of ginsenoside Rb1 were assayed by incubating the re-
action mixture for 24 h at various temperatures ranging from 30C
to 70C at pH 4.8. To determine pH and temperature stability, the
enzyme solution was preincubated in the pH range of 4.0e10.0 and
in the temperature range of 30e70C for 4 h. To determine residual
enzyme activity, the reaction mixture (2.0 mL) containing 2.0 mg of
ginsenoside Rb1 in 0.2 mL methanol, 0.2 mL of enzyme solution,
and 1.6 mL of 0.1M acetate buffer (pH 4.8) was incubated for 24 h at
37C with gentle shaking. The effect of the substrate concentration
on the formation of compound Kwas examined. A reaction mixture
(2.0 mL) containing various amounts of ginsenoside Rb1 (0.5e
5.0 mg) in 0.2 mL of methanol and 1.5 mg of AMMEP containing
0.55 U of b-glucosidase (the weight ratio of ginsenoside Rb1 to
AMMEP being 0.3e3.3:1.0) in 1.8 mL of 0.1M sodium acetate buffer
(pH 4.8) was incubated for 24 h at 37C. The concentrations of each
ginsenoside in the reaction mixtures were calculated from the
calibration curves of standard mixtures. All experiments were
performed in triplicate, and the data were expressed as the
mean  standard deviation.
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3.1. Enzymatic hydrolysis of ginsenoside Rb1
Basidiomycetes mushrooms are not only an important natural
source of foods and therapeutics, but also microorganisms of great
interest that secrete various hydrolytic enzymes such as cellulase,
b-glucosidase, and endo- and exoglucanase [23e25]. Recently,
some studies reported that fermentation of ginseng extracts or
ginseng extraction residues using edible or medicinal mushrooms
could enhance the contents of minor ginsenosides in their products
[16e18]. Therefore, these results indicate that mushroom mycelia
may convert major ginsenosides into deglycosylated minor ginse-
nosides by their carbohydrate hydrolases. We investigated the
possibility of producing minor saponins and/or human intestinal
bacterial metabolites from ginsenoside Rb1 using crude enzyme
preparations from cultured mycelia of ﬁve mushrooms. From the
results, we found that compound K was produced with a high yield
from ginsenoside Rb1 by AMMEP, whereas enzyme preparations
from G. lucidum, P. linteus, E. applanata, and P. ostreatus produced
remarkable amounts of ginsenoside Rd from ginsenoside Rb1
(Fig. 1).
To investigate the pattern of hydrolysis of ginsenoside Rb1 by
AMMEP, the sample was withdrawn at regular intervals duringFig. 2. HPLC analysis of hydrolysis of ginsenoside Rb1 by AMMEP. The reaction conditions ar
theMaterials and methods section. (A) Mixture of authentic ginsenosides, (B) 24-h reaction, (
from cultured mycelia of A. mellea.enzymatic hydrolysis and analyzed by HPLC (Fig. 2). HPLC proﬁles
showed four new peaks, indicating that ginsenoside Rb1 was
gradually hydrolyzed to four metabolites (Ⅰ, Ⅱ, Ⅲ, and Ⅳ). Ginse-
noside Rb1 was hydrolyzed to metabolite Ⅰ in the early stage of the
reaction. After 96 h, almost all of ginsenoside Rb1 andmetabolites I,
II, and III were hydrolyzed to metabolite IV. These results indicate
that metabolites I, II, and III were intermediate metabolites, while
metabolite IV was the ﬁnal product. The reaction mixture was
analyzed by electrospray ionizationeLC/MS to determine the mo-
lecular weight of new metabolites. Peak Ⅰ in Fig. 2 appeared as a
quasimolecular ion peak atm/z 991.54 [M-H þ formic acid]with a
molecular ion peak [M-1] at m/z 945.53, corresponding to the
molecular formula C48H82O18 (molecular weight 946.55; Fig. 3).
Thus, Peak I was attributed to ginsenoside Rd. Peak II also appeared
as a quasimolecular ion peak at m/z 991.55 [M-H þ formic acid]
with a molecular ion peak at m/z 945.55 [M-1], corresponding to
the molecular formula C48H82O18 (molecular weight 946.55).
Therefore, Peak II was attributed to gypenoside XVII. Peaks III and
IV appeared as molecular ion peaks at m/z 829.47 [M-H þ formic
acid] and m/z 667.43 [M-H þ formic acid], corresponding to
quasimolecular ions of ginsenosides F2 and compound K, respec-
tively (Fig. 3). These results indicated that the four metabolites in
Fig. 3 were ginsenoside Rd (Peak I), gypenoside XVII (Peak II),
ginsenoside F2 (Peak III), and compound K (Peak IV) [26].e the same as in Fig. 1. HPLC analysis was performed under the conditions described in
C) 48-h reaction, (D) 72-h reaction, and (E); 96-h reaction. AMMEP, enzyme preparation
Fig. 3. ESIeMS spectra (negative ion mode) of hydrolysis of ginsenoside Rb1 by AMMEP. AMMEP, enzyme preparation from cultured mycelia of A. mellea; ESI, electrospray
ionization; I, ginsenoside Rd; II, gypenoside XVII; III, ginsenoside F2; IV, compound K.
J. Upadhyaya et al / Formation of C-K from Rb1 1093.2. Enzyme characterization
When assayed using PNP-b-D-glucopyranoside as a substrate, b-
glucosidase activity in AMMEP showed optimal activity and sta-
bility at pH 4.0, and was stable between pH 4 and 5. The enzyme
became vulnerable to inactivation below and above this range, and
became inactivated on the extreme alkaline side of the pH proﬁleFig. 4. Hydrolysis of PNP-b-D-glucopyranoside by AMMEP. Effects of (A) pH and (B) tem
containing 0.1 mL of enzyme solution with 0.02 mg of enzyme preparation, 0.1 mL of PNP-
incubated for 30 min at 37C. The reaction was terminated by adding 1.0 mL of 0.1M Na2CO
400 nm. AMMEP, enzyme preparation from cultured mycelia of Armillaria mellea; PNP, p-n(above pH 7.0; Fig. 4A). The optimum temperature and thermal
stability of this enzyme peaked at 50C. The enzymewas stable in a
broad temperature range (25e50C), but the activity decreased
sharply above 60C (Fig. 4B).
The substrate speciﬁcity of AMMEP b-glucosidase was assayed
using 10mM of PNP glycosides with a- and b-conﬁguration. The
results showed that AMMEP b-glucosidase had strong hydrolyticperature on the hydrolysis of PNP-b-D-glucopyranoside. A reaction mixture (1.0 mL)
b-D-glucopyranoside (10mM), and 0.8 mL of sodium acetate buffer (0.1M, pH 4.8) was
3 solution. The released PNP was measured using a UVevisible spectrophotometer at
itrophenol.
Table 1
Relative activity of enzyme preparations from mushroom mycelia on various chromogenic substrates as PNP release.1)
Substrate Armillaria mellea Ganoderma lucidum Phellinus linteus Elfvingia applanata Pleurotus ostreatus
PNP-a-D-glucopyranoside 13.1  1.1 37.5  1.8 7.1  0.5 40.1  0.9 16.1  0.4
PNP-b-D-glucopyranoside 100  2.7 126  4.8 46.5  1.1 181  1.7 201  3.1
PNP-a-D-galactopyranoside 68.6  2.6 350  3.4 10.9  0.2 181  2.6 11.2  0.9
PNP-b-D-galactopyranoside 9.6  0.2 7.2  0.8 50.4  0.6 7.6  0.3 7.9  0.1
PNP-a-L-arabinopyranoside 4.4  0.5 3.7  0.3 0 6.9  0.2 0
PNP-a-L-arabinofuranoside 6.8  0.4 46.4  1.1 0 52.4  1.1 5.7  1.2
PNP-b- D-xylopyranoside 6.4  0.3 13.8  1.2 4.3  0.2 5.1  0.2 31.8  0.4
PNP, p-nitrophenol
1) The activity was assayed with 10mM of substrates at 37C. The relative activity was based on the hydrolytic activity of PNP-b-D-glucopyranoside in the enzyme prep-
aration from A. mellea
Fig. 5. Time course of the hydrolysis of ginsenoside Rb1 by AMMEP. The reaction was
performed under the conditions described in the Materials and methods section.
AMMEP, enzyme preparation from cultured mycelia of A. mellea; CeK, compound K.
J Ginseng Res 2016;40:105e112110activities toward PNP-b-D-glucopyranoside and PNP-a-D-gal-
actopyranoside. As shown in Table 1, the enzyme preparations from
cultured mycelia of G. lucidum, A. applanata, and P. ostreatus also
showed strong hydrolytic activities toward PNP-b-D-Fig. 6. Hydrolysis of ginsenoside Rb1 by AMMEP. Effects of (A) pH and (B) temperature on t
reaction mixture (2.0 mL) containing 2.0 mg of ginsenoside Rb1 in 0.2 mL of methanol and AM
was incubated for 24 h 37C. The optimum temperature was determined by incubating the re
hydrolysis products were analyzed by HPLC under the conditions described in the Materials
CeK, compound K.glucopyranoside. Interestingly, these enzyme preparations exhibi-
ted no hydrolyzing activities for converting ginsenoside Rb1 into
ginsenoside F2 or compound K. These results demonstrate that b-
glucosidases from G. lucidum, P. linteus, E. applanata, and P. ostreatus
mycelia selectively hydrolyzed b-(1/6)-glucosidic linkage of gin-
senoside Rb1, without attacking b-(1/2)-glucosidic linkage in
spite of their potent b-glucosidase activities. These results were
similar to those of ginsenoside Rb1-hydrolyzing b-D-glucosidases
puriﬁed from China white jade snail [27] and Cladosporium fulvum
[28]. The reason for this might be that the spatial conﬁguration of
ginsenoside molecule blocked the attack of enzyme to b-(1/2)-
glucosidic linkage in linked at the C3-hydroxy group of aglycone
[28].
3.3. Effect of reaction conditions on the hydrolysis of ginsenoside
Rb1
In relation to the effect of reaction time, ginsenoside Rb1 was
gradually hydrolyzed into ginsenoside Rd at the early stages of the
reaction (Fig. 5). However, a remarkable formation of compound K
was not observed within 24 h. When the reaction time was
increased from 24 h to 72 h, a signiﬁcant amount of ginsenoside Rd
was converted into ginsenoside F2 or compound K. After 72e96 h
of incubation, ginsenosides Rd and F2 were almost completely
hydrolyzed to compound K. The optimum pH range for compound
K formation from ginsenoside Rb1 was 4.0e4.5 (Fig. 6A). These
results indicate that ginsenoside Rb1was converted to compound Khe hydrolysis of ginsenoside Rb1. To determine the optimum pH and temperature, the
MEP containing 1.1 U of b-glucosidase activity in 1.8 mL of 0.1M acetate buffer (pH 4.8)
action mixture for 24 h at temperatures in the range of 30e70C. Concentrations of the
and methods section. AMMEP, enzyme preparation from cultured mycelia of A. mellea;
Fig. 7. Effects of ginsenoside Rb1 concentration on the formation of compound K by
AMMEP. The reaction mixture (2.0 mL) containing various amounts of ginsenoside Rb1
ranging from 0.5 mg to 5.0 mg in 0.2 mL of methanol, and 1.5 mg of AMMEP (the
weight ratio of ginsenoside Rb1 to AMMEP being 0.3e3.3:1.0) in 1.8 mL of 0.1M sodium
acetate buffer (pH 4.8) was incubated for 24 h at 45C. The ratio of conversion products
was expressed as percentage of the HPLC peak area. AMMEP, enzyme preparation from
cultured mycelia of Armillaria mellea; CeK, compound K.
Fig. 8. Proposed pathway of the enzymatic hydrolysis of ginsenoside Rb1 by AMMEP. AMMEP, enzyme preparation from cultured mycelia of Armillaria mellea.
J. Upadhyaya et al / Formation of C-K from Rb1 111via Rd and F2 at pH 4.0e4.5.When the pHwas increased to 5.0e6.0,
the rate of formation of compound K decreased. Furthermore, for-
mation of compound K was not observed in the pH range of 6.5e
10.0. From the above result, it was concluded that a weak acidic
condition is ideal for the formation of compound K from ginseno-
side Rb1. The inﬂuence of pH on enzymatic hydrolysis of ginseno-
side Rb1 to compound K has extensively been studied with
enzymes obtained from various sources, and the optimum pH for
ginsenoside hydrolysis of many microbial enzymes is in the range
of 3.5e7.5 [14,29].
As shown in Fig. 6B, the ginsenoside Rb1-hydrolyzing activity of
AMMEP b-glucosidase was greatly inﬂuenced by the reaction
temperature. Ginsenoside Rb1 was incubated with AMMEP for 24 h
at different temperatures (30e70C). Initially, at 30e35C, ginse-
noside Rb1 began to hydrolyze into ginsenosides Rd and F2. As the
reaction temperature was increased to 45e55C, intermediate
metabolites ginsenosides Rd and F2 were signiﬁcantly hydrolyzed
into compound K. When the reaction temperature was increased to
60e70C, formation of compound K decreased. The results suggest
that the optimum temperature for the formation of compound K
from ginsenoside Rb1 by AMMEP b-glucosidase is in the range of45e55C. Generally, the optimum temperatures for ginsenoside-
hydrolyzing enzymes from human intestinal bacteria and soil mi-
croorganisms are in the range of 37e45C [14,29]. The effect of
ginsenoside Rb1 concentration on the formation of compound K
was examined. The results showed that as the concentration of
ginsenoside Rb1 in the reaction mixture was increased, the quan-
tity of compound K decreased. Ginsenoside Rb1 was also
completely hydrolyzed to compound K when incubated with a
large quantity of AMMEP (the weight ratio of ginsenoside Rb1 to
AMMEP being 1:3; Fig. 7).
3.4. Pathway of enzymatic formation of compound K from
ginsenoside Rb1
As ginsenoside Rb1 contains four molecules of glucose with b-
glucosidic linkages, it can be hydrolyzed by b-glucosidase through
different pathways with multiple steps. Judging from the results of
TLC, HPLC, and LC/MS analyses of the hydrolysis products of gin-
senoside Rb1 in this study, b-glucosidase from AMMEP ﬁrst hy-
drolyzes the outer glucose moiety attached to the C-20 position of
aglycone to produce ginsenoside Rd. Thereafter, the outer glucose
moiety is attached to the C-3 position of the aglycone to produce
ginsenoside F2. This is followed by detachment of the inner glucosemoiety from the C-3 position to produce compound K. Therefore,
we suggested that AMMEP b-glucosidase exploits the hydrolytic
pathway of ginsenoside Rb1 / Rd / F2 / compound K, along
with a minor pathway involving ginsenoside Rb1 / gypenoside
XVII/ F2/ compound K (Fig. 8).
The hydrolytic pathway is determined by the stereospeciﬁc
preference of the enzyme for the sugars attached to C-3 or C-20
position of the aglycone in ginsenoside Rb1 [29]. Previous studies
showed that the b-glucosidases from Lactobacillus pentosus DC101
[30] and Paecilomyces bainier [31] exploit the hydrolytic pathway
involving ginsenoside Rb1/ Rd/ F2/ compound K. However,
b-glucosidases from Fusobacterium sp [32]. exploit two hydrolytic
pathways: ginsenoside Rb1 / Rd / F2 / compound K and
gypenoside XVII/ F2/ compound K.
In conclusion, we prepared enzyme preparations from cultured
mycelia of ﬁve edible and/or medicinal mushrooms. Among them,
AMMEP b-glucosidase showed potent activity in hydrolysis of
ginsenoside Rb1 to compound K. The optimum conditions for
compound K formation from ginsenoside Rb1 were as follows:
reaction time of 72e96 h, pH of 4.0e4.5, and temperature range
of 45e55C. This result suggests that AMMEP can be used to
J Ginseng Res 2016;40:105e112112produce the human intestinal bacterial metabolite compound K
from ginsenoside Rb1 with a high yield and without food safety
problems.
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